• Explore /
  • Poster
  • / Effect of antibiotic, proton pump inhibitor, H2 blocker, metformin and statin use on outcomes with immune checkpoint inhibitors (ICIs) in patients (pts) with metastatic urothelial carcinoma (mUC) in a real-world setting.

Effect of antibiotic, proton pump inhibitor, H2 blocker, metformin and statin use on outcomes with immune checkpoint inhibitors (ICIs) in patients (pts) with metastatic urothelial carcinoma (mUC) in a real-world setting.

Abstract Poster

Authors

Charbel Hobeika

Charbel Hobeika

Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Charbel Hobeika , Scott Dawsey , Ubenthira Patgunarajah , David Lynn , Nikhil Pramod , Wei Wei , Monica Nair , Kimberly Maroli , Allison Martin , Moshe Chaim Ornstein , Christopher Eing Wee , Timothy D. Gilligan , Amanda Nizam , Amanda Bonham , Omar Y. Mian , Paul G. Jr., C. Marcela Diaz-Montero , Shilpa Gupta

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Urothelial Cancer - Advanced/Metastatic Disease

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 4589)

DOI

10.1200/JCO.2024.42.16_suppl.4589

Abstract #

4589

Poster Bd #

284

Abstract Disclosures

Similar Posters

First Author: Ubenthira Patgunarajah

First Author: Guru P. Sonpavde

First Author: Rafael Morales-Barrera

First Author: Yukiko Shimoda Igawa